by Benzinga Insights | Oct 23, 2026 | General
Balchem (NASDAQ:BCPC) reported third-quarter financial results on Friday. The transcript from the company’s third-quarter earnings call has been provided below.This transcript is brought to you by Benzinga APIs. For real-time access to our entire catalog, please visit...
by Benzinga Insights | Oct 23, 2026 | General
TD Synnex (NYSE:SNX) has outperformed the market over the past 20 years by 7.82% on an annualized basis producing an average annual return of 16.76%. Currently, TD Synnex has a market capitalization of $19.85 billion. Buying $100 In SNX: If an investor had bought $100...
by Vandana Singh | Oct 23, 2026 | General
Aardvark Therapeutics Inc. (NASDAQ:AARD) stock plunged on Friday after the release of exploratory efficacy data from its terminated Phase 3 HERO trial and open-label extension study. The biopharmaceutical company unblinded the accumulated data to evaluate the safety...
by Anusuya Lahiri | Oct 23, 2026 | General
Infosys Ltd. (NYSE:INFY) stock fell Friday after the Indian IT services company reported weaker-than-expected second-quarter fiscal 2027 earnings and revenue and lowered its full-year sales outlook amid softer demand and pricing pressure. Revenue rose 1.3% year over...
by Vandana Singh | Oct 23, 2026 | General
Tango Therapeutics Inc. (NASDAQ:TNGX) on Friday shared Phase 1/2 trial data for its investigational drug vopimetostat, revealing strong efficacy in treating advanced pancreatic and lung cancers. The biotechnology firm reported marked tumor shrinkage when combining the...
Recent Comments